Patrick Vallance, President - R&D, GlaxoSmithKline said the company is looking forward to more collaborations and is looking at a number of options to move ahead with its expansion plans.
According to Pharmexcil Director General PV Appaji, depreciation of Russian rouble, coupled with the Ukraine situation, mainly led to a degrowth in overall pharma exports